Immediate Impact

23 from Science/Nature 74 standout
Sub-graph 1 of 19

Citing Papers

CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
Biological functions of lymphatic vessels
2020 StandoutScience
2 intermediate papers

Works of Susan Jones‐Bolin being referenced

Synthesis and Biological Profile of the pan-Vascular Endothelial Growth Factor Receptor/Tyrosine Kinase with Immunoglobulin and Epidermal Growth Factor-Like Homology Domains 2 (VEGF-R/TIE-2) Inhibitor 11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): A Novel Oncology Therapeutic Agent
2011
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo
2002

Author Peers

Author Last Decade Papers Cites
Susan Jones‐Bolin 418 182 337 184 14 762
Cédric Leroy 509 251 191 142 20 851
Francesca Pellicano 452 157 564 349 26 978
Katie O’Callaghan 477 153 300 111 19 896
M Durstin 380 197 304 190 11 780
Celia Sigua 734 144 264 89 15 940
Letetia C. Jones 261 68 338 214 16 685
Sandrine Guérin 464 184 93 54 16 814
William Lento 546 155 280 134 16 869
Tadaaki Kishi 293 187 204 401 17 732
Pu Zhang 445 198 299 144 18 864

All Works

Loading papers...

Rankless by CCL
2026